(Q30389474)

21 June 2017

1 reference

title

The global burden of diabetes and its complications: an emerging pandemic (English)

1 reference

21 June 2017

0 references

Yvonne T van der Schouw

object named as

Yvonne T van der Schouw

series ordinal

3

0 references

Diederick Grobbee

series ordinal

4

object named as

Diederick E Grobbee

1 reference

21 June 2017

2

Joline W J Beulens

1 reference

21 June 2017

1

Susan van Dieren

1 reference

21 June 2017

Bruce Neal

5

1 reference

21 June 2017

language of work or name

1 reference

1 May 2010

1 reference

European Journal of Cardiovascular Prevention and Rehabilitation

21 June 2017

published in

1 reference

21 June 2017

volume

17 Suppl 1

1 reference

21 June 2017

page(s)

S3-8

1 reference

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Low yield of population-based screening for Type 2 diabetes in the Netherlands: the ADDITION Netherlands study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

The Prevalence and Management of Diabetes in Rural India

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Predictive Properties of Impaired Glucose Tolerance for Cardiovascular Risk Are Not Explained by the Development of Overt Diabetes During Follow-Up

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Diabetes and it's complications in a Swedish county.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Risk factors for renal failure: the WHO Mulinational Study of Vascular Disease in Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Prevalence and incidence of Type 2 diabetes and its complications 1996-2003--estimates from a Swedish population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Overview of epidemiologic studies of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Nine-year incidence of visual impairment in the Barbados Eye Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

The appearance of retinopathy and progression to proliferative retinopathy: the WHO Multinational Study of Vascular Disease in Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

The burden of diabetes and its complications: trends and implications for intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Changes in the diabetic retinopathy epidemiology after 14 years in a population of Type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Changes in incidence of diabetes mellitus-related eye disease among US elderly persons, 1994-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Diabetes retinopathy screening: audit of equity in participation and selected outcomes in South East London

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

The incidence of visual impairment and its determinants in the WHO Multinational Study of Vascular Disease in Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES-55).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Prevalence of peripheral neuropathy in type 2 diabetic patients attending a diabetes center in Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Diabetes mortality: new light on an underestimated public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

Risk Factors for Stroke in Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

U.K. Prospective Diabetes Study 22: Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368191.86614.5A

10.1097/01.HJR.0000368191.86614.5A

21 January 2018

Identifiers

DOI

1 reference

21 June 2017

1 reference